Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E32.65 EPS (ttm)2.66 Insider Own0.20% Shs Outstand728.79M Perf Week1.24%
Market Cap63.29B Forward P/E14.45 EPS next Y6.01 Insider Trans-7.52% Shs Float726.94M Perf Month4.64%
Income2.01B PEG2.53 EPS next Q1.10 Inst Own88.20% Short Float2.73% Perf Quarter2.47%
Sales100.89B P/S0.63 EPS this Y14.30% Inst Trans-0.28% Short Ratio5.50 Perf Half Y18.86%
Book/sh27.48 P/B3.16 EPS next Y10.70% ROA3.70% Target Price94.33 Perf Year22.24%
Cash/sh2.51 P/C34.53 EPS next 5Y12.90% ROE9.70% 52W Range64.64 - 89.59 Perf YTD2.56%
Dividend- P/FCF15.39 EPS past 5Y11.20% ROI7.60% 52W High-2.29% Beta1.16
Dividend %- Quick Ratio0.50 Sales past 5Y32.50% Gross Margin8.30% 52W Low35.43% ATR1.62
Employees29500 Current Ratio0.60 Sales Q/Q2.10% Oper. Margin4.60% RSI (14)57.36 Volatility1.58% 2.02%
OptionableYes Debt/Eq0.68 EPS Q/Q21.50% Profit Margin2.00% Rel Volume0.89 Prev Close86.84
ShortableYes LT Debt/Eq0.55 EarningsApr 28 AMC Payout0.00% Avg Volume3.61M Price87.54
Recom2.20 SMA201.44% SMA503.04% SMA20011.16% Volume1,126,263 Change0.81%
Mar-10-15Reiterated RBC Capital Mkts Outperform $82 → $87
Feb-24-15Reiterated Mizuho Buy $94 → $98
Feb-24-15Reiterated Maxim Group Buy $90 → $109
Jan-28-15Downgrade FBR Capital Outperform → Mkt Perform
Jan-08-15Reiterated Mizuho Buy $82 → $94
Dec-16-14Reiterated Oppenheimer Outperform $82 → $88
Dec-15-14Reiterated UBS Buy $82 → $96
Dec-04-14Reiterated Deutsche Bank Hold $76 → $88
Dec-03-14Reiterated Barclays Overweight $83 → $94
Oct-30-14Reiterated RBC Capital Mkts Outperform $73 → $82
Jul-30-14Reiterated FBR Capital Outperform $79 → $74
Jul-28-14Reiterated UBS Buy $90 → $82
May-01-14Reiterated Maxim Group Buy $92 → $90
Apr-30-14Reiterated Mizuho Buy $86 → $82
Mar-06-14Reiterated Deutsche Bank Hold $75 → $79
Mar-05-14Reiterated RBC Capital Mkts Outperform $72 → $84
Mar-05-14Initiated Barclays Overweight $85
Feb-21-14Reiterated FBR Capital Outperform $75 → $83
Feb-19-14Reiterated Maxim Group Buy $80 → $92
Feb-18-14Downgrade Monness Crespi & Hardt Buy → Neutral
Apr-28-15 07:07AM  Q1 2015 Express Scripts Holding Co Earnings Release - After Market Close
Apr-27-15 03:12PM  Will Express Scripts (ESRX) Disappoint Earnings in Q1? - Analyst Blog
Apr-21-15 08:45AM  Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs at noodls
08:30AM  Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs PR Newswire
Apr-20-15 04:10PM  UnitedHealth Groups Optum Posts Healthy 1Q15 Operating Earnings
01:01PM  John Shapiros Value Investing Picks Pay Off Big Time In First Quarter at Insider Monkey
09:01AM  These Five Positions Hurt Hedge Funds the Most Last Week
Apr-18-15 11:10AM  Why Walgreens Won't Buy A PBM Anytime Soon at Forbes
Apr-16-15 06:14PM  AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
05:54PM  Why CVS Health And McKesson May Be Good Stock Picks at Investor's Business Daily
02:12PM  Exciting time for drug breakthroughs: Merck CEO
06:27AM  UnitedHealthcare Q1 earnings beats Street
Apr-10-15 09:30AM  Will Walgreens make a run for Express Scripts? at bizjournals.com
Apr-09-15 06:00PM  Express Scripts, Silicon Motion, Apogee Break Out at Investor's Business Daily
06:00PM  Cramer: Invest in best of breed
05:10PM  Gap shares decline as sales fall at namesake store at MarketWatch
03:29PM  Express Scripts climbs as Walgreens states interest in deals
10:41AM  Stocks Wobble At Starting Line; Express Scripts Up, Altera Dips at Investor's Business Daily
Apr-08-15 04:55PM  Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call at noodls
04:30PM  Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call GlobeNewswire
Apr-04-15 12:01AM  After Rising 80%, UnitedHealth Looks Pricey at Barrons.com
Apr-01-15 09:30AM  The Zacks Analyst Blog Highlights: UnitedHealth Group, Catamaran, CVS Health, Express Scripts and Rite Aid - Press Releases
07:50AM  SIOR chapter announces deals of the year for western Pennsylvania at bizjournals.com
Mar-31-15 02:43PM  Express Scripts (ESRX) Stock Is Up Today on Heavy Trading Volume at TheStreet
02:40PM  13 CEOs who hang out at the White House
02:20PM  Breakout time for Express Scripts?
02:00PM  UnitedHealth Arm to Boost Pharmacy Benefits with Catamaran - Analyst Blog
11:06AM  Post-UNH Deal, Spotlight on Pharmacy Benefit Stocks - Analyst Blog
12:29AM  [$$] UnitedHealth to Buy Catamaran for $12.8 Billion in Cash at The Wall Street Journal
Mar-30-15 11:00PM  Catamaran Corporation -- Moody's puts Catamaran's ratings on review for upgrade following news of acquisition by OptumRx at Moody's
07:41PM  UnitedHealth Pays $12.8 Bil To Double Prescription Clients
06:30PM  UnitedHealth Group Incorporated -- Moody's affirms UnitedHealth's ratings (sr. debt at A3) on announced acquisition; outlook changed to negative from stable at Moody's
06:10PM  UnitedHealth to Buy Catamaran for $12.8 Billion at The Wall Street Journal
05:32PM  UnitedHealth bulks up for prescription drug cost battle
05:30PM  Stocks End Higher on China Easing Hopes, M&A Activity
03:22PM  UnitedHealth-Catamaran deal sets up healthcare M&A chessboard
02:19PM  Fight Over High-Cost Drugs to Intensify After Catamaran Deal at Bloomberg
02:03PM  UnitedHealth's $12.8B deal
01:20PM  UnitedHealth: changing the channel at Financial Times
01:00PM  Catamaran leads Nasdaq
12:00PM  Stocks Rise After China Easing Hopes, M&A Activity
11:40AM  UnitedHealth: Catamaran Acquisition 'Checks Three Important Boxes' at Barrons.com
09:54AM  UnitedHealth to buy pharmacy benefits manager Catamaran at Los Angeles Times
09:09AM  UnitedHealth's $12.8 Billion Answer To Expensive Prescription Drugs at Forbes
09:00AM  UnitedHealth Acquires Catamaran, Creating a Top-Tier PBM at Morningstar
08:02AM  UnitedHealth to buy pharmacy benefits manager Catamaran AP
Mar-27-15 10:28AM  5 Big Breakout Stocks to Trade for Big Gains: Must-See Charts at TheStreet
Mar-26-15 05:30PM  Biotech's rough ride over?
Mar-18-15 10:28AM  The Scariest Health Care Statistic of 2014
09:30AM  Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases
Mar-17-15 08:42AM  Critical Reports Mount On Hepatitis C Pill Costs at Forbes
Mar-16-15 04:00PM  Prescription drug spending has gone through the roof and now we know why
12:57PM  Buy These Stocks to Avoid Dollar Damage, Goldman Sachs Says at Barrons.com
Mar-13-15 03:33PM  These cholesterol drugs stocks are poised to move at CNBC
Mar-12-15 07:14AM  CVS: Copycat drugs may bring price cuts of 40-50% at CNBC
Mar-11-15 03:31PM  Express Scripts Issues Report on Prescription Drug Spending - Analyst Blog
01:05PM  3 Attractive Stocks To Buy -- At A Sizeable Discount at Forbes
12:43PM  Wolfe Research Analysts: 'Good News ... More Drugs!'
Mar-10-15 01:30PM  CNBC update: Prescription drug spending up
12:49PM  Hepatitis C Meds Absorb Most Of 13% Jump In Drug Spending
12:49PM  Drug Spending Accelerated In 2014: Express Scripts at Investor's Business Daily
12:30PM  Hepatitis C drugs drive 13% jump in medicine spending at MarketWatch
09:18AM  Report: Specialty drugs drive prescription spending jump
08:53AM  What!?! Specialty drug spending jumps 31% at CNBC
08:26AM  Hepatitis C pills drive surge in U.S. drug costs -report
07:05AM  US specialty drug spending trends in 2015 CNBC
07:04AM  Prescription drug prices rising: Report CNBC
07:00AM  U.S. Prescription Drug Spending Increased 13.1 Percent in 2014, Driven by Hepatitis C and Compounded Medications PR Newswire
12:28AM  [$$] Expensive Hepatitis C Medications Drive Prescription-Drug Spending at The Wall Street Journal
12:01AM  Drug Costs Grew Last Year at Fastest Rate in Decade, Report Says at Bloomberg
12:00AM  Hepatitis Pills Spark Biggest Jump In Drug Costs In A Decade at Forbes
Mar-07-15 09:30AM  First Copycat Biotech Drug Spurs $250B Obamacare Savings at Forbes
Mar-06-15 09:57PM  U.S. Clears First Copycat Biotech Drug, Jolting Sector at The Wall Street Journal
07:15PM  FDA Approves First Copy of a Biotech Drug at The Wall Street Journal
Mar-04-15 01:44PM  Three trades to go before the closing bell at CNBC
12:59PM  FMHR Final Trade: ESRX, EXXI & JNJ CNBC
10:10AM  UBS Makes Big Changes to Equity Focus List For March at 24/7 Wall St.
Mar-02-15 02:19PM  Rolfe: We'll own Berkshire many years to come CNBC
10:00AM  An Obamacare ETF Keeps Rising ETF Trends
Feb-28-15 11:04AM  5 Stocks Warren Buffett Is Selling: Exxon, ConocoPhillips and More at TheStreet
Feb-27-15 11:48AM  Horizon Pharma Soars On Q4 Beat, Guidance Raise at Investor's Business Daily
08:30AM  Trade Healthcare Providers with this ETF at Investopedia
Feb-26-15 03:55PM  Health Care Stocks Flexing Their Muscle at Forbes
02:19PM  The Drug Pipeline Flows Again at Bloomberg
11:59AM  Catamaran EPS Tops, But Stock Falls On Weak Guidance at Investor's Business Daily
11:08AM  6 reasons biotech stocks may soon tank at MarketWatch
Feb-25-15 02:19PM  Express Scripts Holding (ESRX) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
12:09PM  Story Stocks from Briefing.com Briefing.com
10:38AM  Gilead & AbbVie: It Doesn't Matter Which Drug is Better, Just Who Will Pay at Barrons.com
Feb-24-15 05:30PM  Stocks End at New Record Highs; Yellen, Grecce Eyed Morningstar
12:00PM  Stocks Rise; Yellen Testimony, Greece in Focus Morningstar
10:21AM  Waiting for Yellen Q&A, but QE helping elsewhere at CNBC
10:10AM  Company News for February 24, 2015 - Corporate Summary Zacks
09:30AM  Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog Zacks
09:10AM  What We're Trading Yahoo Finance Contributors
08:52AM  Morning Movers: JPMorgan Shares Higher on Investor Day; Home Depot Jumps on Earnings at Barrons.com
08:30AM  Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today CCBN
08:15AM  Early movers: HD, CMCSA, TOL, ODP, JPM & more at CNBC
Feb-23-15 07:00PM  Cramer: Watch out - regulators are gunning for these stoc... CNBC
05:46PM  First Solar, SunPower shares surge on joint IPO at MarketWatch
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company's PBM segment's services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 02Sale84.392,674225,6598,291Mar 03 04:15 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 25Sale87.315,864511,98610,965Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Option Exercise47.6121,7391,034,99438,568Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Sale87.6221,7391,904,77016,829Feb 26 04:03 PM
Ebling Keith J.Exec. VP and General CounselDec 02Sale84.2510,000842,5000Dec 03 04:04 PM
Miller Steven BSr. VP & Chief Med. OfficerDec 01Sale83.574,896409,14416,521Dec 03 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Option Exercise47.6110,800514,18830,657Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Sale82.9610,800895,94619,857Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Option Exercise47.6110,874517,71130,731Nov 25 04:38 PM
MAC MAHON THOMAS PDirectorNov 21Option Exercise35.8512,694455,01654,066Nov 25 04:40 PM
MAC MAHON THOMAS PDirectorNov 21Sale80.9312,6941,027,35141,372Nov 25 04:40 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Sale81.5010,874886,23119,857Nov 25 04:38 PM
PARKER JOHN ODirectorNov 17Option Exercise33.3025,822859,75365,503Nov 18 05:04 PM
PARKER JOHN ODirectorNov 17Sale78.7525,8222,033,43139,681Nov 18 05:04 PM
Breen Maura CDirectorNov 07Option Exercise30.8313,128404,73630,438Nov 10 04:16 PM
Breen Maura CDirectorNov 07Sale77.8013,1281,021,34517,310Nov 10 04:16 PM
IGNACZAK EDWARD BEVPSep 05Sale75.289,886744,21675,996Sep 09 05:01 PM
STERNBERG SEYMOURDirectorAug 28Option Exercise54.3015,508842,07920,277Sep 02 04:07 PM
STERNBERG SEYMOURDirectorAug 28Sale74.1215,5081,149,3914,769Sep 02 04:07 PM
Ebling Keith J.Exec. VP and General CounselAug 25Sale75.5010,000755,00010,000Aug 26 04:04 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Option Exercise53.0520,0001,061,00049,532Aug 06 04:10 PM
BENANAV GARY GDirectorAug 05Option Exercise35.8512,694455,01655,705Aug 07 04:08 PM
BENANAV GARY GDirectorAug 05Sale70.8212,694898,98943,011Aug 07 04:08 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Sale70.4420,0001,408,80029,532Aug 06 04:10 PM
Norton David ASenior VP, Supply ChainAug 04Sale71.021,27690,6270Aug 06 04:13 PM
Breen Maura CDirectorAug 01Option Exercise35.8512,694455,01630,283Aug 05 04:55 PM
Breen Maura CDirectorAug 01Sale69.9412,694887,75517,589Aug 05 04:55 PM
PAZ GEORGEChairman & CEOJun 13Option Exercise26.68681,50818,179,3841,469,761Jun 17 05:04 PM
PAZ GEORGEChairman & CEOJun 13Sale71.21681,50848,530,185788,253Jun 17 05:04 PM
WENTWORTH TIMOTHY CPresidentMay 27Option Exercise47.25127,1896,009,516228,492May 29 05:03 PM
WENTWORTH TIMOTHY CPresidentMay 27Sale70.47105,6777,447,058122,815May 29 05:03 PM